Mindfulness Adjunct Lowers Anxiety Scores in Medicated Adults With GAD

Generalized anxiety disorder remains a significant clinical challenge, often requiring a multi-modal approach to achieve full symptomatic remission. While selective serotonin reuptake inhibitors and other pharmacotherapies are standard first-line treatments, a substantial proportion of patients experience treatment resistance or residual symptoms that impair daily functioning [1]. Mindfulness-based interventions have emerged as potential adjuncts, showing efficacy in reducing anxiety and depression across various populations, including university students and those with treatment-resistant conditions [2, 3]. Recent evidence suggests that these interventions may be particularly effective for addressing specific symptoms like worry, though their impact can be influenced by individual patient histories [4]. While cognitive behavioral therapy remains a standard psychotherapeutic option, mindfulness-based cognitive therapy may offer distinct short-term benefits in symptom reduction for those with active diagnoses [5]. A new randomized controlled trial now evaluates the specific impact of integrating these practices into the standard care of medicated patients.